Therapeutic Products Regulation – Replacement of the Medicines Act 1981 and the Medicines Regulations 1984 with a new legislative scheme for therapeutic products

This regulatory impact statement provides an analysis of options to change the regulation of therapeutic products. These include medicines, medical devices, and cell and tissue therapies and combinations thereof. The purpose of change is to advance coverage, safety, quality and access objectives.